Redwood Bioscience's Series B Round

Redwood Bioscience raised a round of funding on January 28, 2014.

Redwood Bioscience is developing SMARTag technology, a precision-protein chemical engineering platform, to produce the next generation of antibody-drug conjugates and other semi-synthetic biotherapeut…

Articles about Redwood Bioscience's Series B Round: